Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial

American Journal of Hematology

Volumn 82, Issue 11, 2007, Pages 955-960

  Van Beers, Eduard J ^a   Van Tuijn, Charlotte F J ^a   Nieuwkerk, Pythia T ^a   Friederich, Philip W ^a   Vranken, Jan H ^a   Biemond, Bart J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NALOXONE;

ACUTE CHEST SYNDROME; ADULT; ARTICLE; BLOOD VESSEL OCCLUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG UTILIZATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; MALE; NAUSEA; PAIN; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEDATION; SICKLE CELL ANEMIA; SIDE EFFECT; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; ANEMIA, SICKLE CELL; FEMALE; HUMANS; MALE; MORPHINE; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 35549003236     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20944     Document Type: Article

References (36)

1. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease - life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-1644.
2. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1997;337:762-769.
3. Davies SC, Oni L. Fortnightly review: Management of patients with sickle cell disease. BMJ 1997;315:656-660.
4. Kopecky EA, Jacobson S, Joshi P, Koren G. Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease. Clin Pharmacol Ther 2004;75:140-146.
5. The National Institutes of Health. Treatment of acute and chronic complications: Pain. In: Adams R, Ataga KI, Ballard H, et al., eds. The Management of Sickle Cell Disease, 4th ed. Washington: The National Institutes of Health and National Heart, Blood, and Lung Institute; 2002. pp. 59-74.
6. Dunlop R, Bennett K. Pain management for sickle cell disease. Cochrane Database Syst Rev 2006;(2):CD003350.
7. Gonzalez ER, Bahal N, Hansen LA, et al. Intermittent injection vs. patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department. Arch Intern Med 1991;151:1373-1378.
8. Trentadue NO, Kachoyeanos MK, Lea G. A comparison of two regimens of patient- controlled analgesia for children with sickle cell disease. J Pediatr Nurs 1998;13:15-19.
9. Hansen LA, Noyes MA, Lehman ME. Evaluation of patient-controlled analgesia (PCA) versus PCA plus continuous infusion in postoperative cancer patients. J Pain Symptom Manage 1991;6:4-14.
10. Mackie AM, Coda BC, Hill HF. Adolescents use patient-controlled analgesia effectively for relief from prolonged oropharyngeal mucositis pain. Pain 1991;46:265-269.
11. Baubillier E, Leppert C, Delaunay L, Bonnet F. Patient-controlled analgesia: Effect of adding continuous infusion of morphine. Ann Fr Anesth Reanim 1992;11:479-483.
12. Russell AW, Owen H, Ilsley AH, et al. Background infusion with patient- controlled analgesia: Effect on postoperative oxyhaemoglobin saturation and pain control. Anaesth Intens Care 1993;21:174-179.
13. Paoletti F, Ciammitti B, Tosti F, et al. Postoperative intravenous analgesia. Minerva Anestesiol 1993;59:523-530.
14. Doyle E, Robinson D, Morton NS. Comparison of patient-controlled analgesia with and without a background infusion after lower abdominal surgery in children. Br J Anaesth 1993;71:670-673.
15. Doyle E, Harper I, Morton NS. Patient-controlled analgesia with low dose background infusions after lower abdominal surgery in children. Br J Anaesth 1993;71:818-822.
16. Bray RJ, Woodhams AM, Vallis CJ, Kelly PJ. Morphine consumption and respiratory depression in children receiving postoperative analgesia from continuous morphine infusion or patient-controlled analgesia. Paediatr Anaesth 1996;6:129-134.
17. Dawson PJ, Libreri FC, Jones DJ, et al. The efficacy of adding a continuous intravenous morphine infusion to patient-controlled analgesia (PCA) in abdominal surgery. Anaesth Intens Care 1995;23:453-845.
18. Smythe MA, Zak MB, O'Donnell MR et al. Patient-controlled analgesia versus patient-controlled analgesia plus continuous infusion after hip replacement surgery. Ann Pharmacother 1996;30:224-227.
19. Peters JW, Bandell H, Huijer I, et al. Patient-controlled analgesia in children and adolescents: A randomized controlled trial. Paediatr Anaesth 1999; 9:235-241.
20. Guler T, Unlugenc H, Gundogan Z, et al. A background infusion of morphine enhances patient-controlled analgesia after cardiac surgery. Can J Anaesth 2004;51:718-722.
21. Draycott S, Dabbs A. Cognitive dissonance, Part 1: An overview of the literature and its integration into theory and practice in clinical psychology. Br J Clin Psychol 1998;37:341-353.
22. Egan KJ. What does it mean to a patient to be "in control". In: Ferrante FM, Ostheimer GW, Cousins BG, editors. Patient Controlled Analgesia. 1990 ed. Cambridge, MA: Blackwell. Scientific Publications; 2007, pp. 17-26.
23. Britto MT, DeVellis RF, Hornung RW, et al. Health care preferences and priorities of adolescents with chronic illnesses. Pediatrics 2004;114:1272-1280.
24. Maxwell K, Streetly A, Bevan D. Experiences of hospital care and treatment seeking for pain from sickle cell disease: Qualitative study. BMJ 1999; 318: 1585-1590.
25. Berde CB, Lehn BM, Yee JD, et al. Patient-controlled analgesia in children and adolescents: A randomized, prospective comparison with intramuscular administration of morphine for postoperative analgesia. J Pediatr 1991;118: 460-466.
26. Bray RJ, Woodhams AM, Vallis CJ, et al. A double-blind comparison of morphine infusion and patient-controlled analgesia in children. Paediatr Anaesth 1996;6:121-127.
27. Owen H, Kluger MT, Plummer JL. Variables of patient-controlled analgesia, Part 4: The relevance of bolus dose size to supplement a background infusion. Anaesthesia 1990;45:619-622.
28. Chumbley GM, Hall GM, Salmon P. Patient-controlled analgesia: An assessment by 200 patients. Anaesthesia 1998;53:216-221.
29. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11-16.
30. Holdgate A, Asha S, Craig J, Thompson J. Comparison of a verbal numeric rating scale with the visual analogue scale for the measurement of acute pain. Emerg Med (Fremantle) 2003;15:441-446.
31. Kremer E, Atkinson JH, Ignelzi RJ. Measurement of pain: Patient preference does not confound pain measurement. Pain 1981;10:241-248.
32. Jacob E, Miaskowski C, Savedra M, et al. Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease. Pain 2003;102:187-193.
33. Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: A validation study. J Pain Symptom Manage 2003;25:406-411.
34. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
35. Ware JE, Kosinski M., Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: The Health Institute, New England Medical Center: 2005.
36. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000;342:1855-1865.